20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
EFFICIENT FUNCTIONAL GENOMICS PLATFORM
#2702AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-W
#2703CARTILAGE-BINDING FUSION PROTEINS
#2704Compositions and methods for modulation of immune function
#2705Methods and uses of slit for treating fibrosis
#2706P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY
#2707Lung injury repair compositions and methods
#2708EXOSOMES FOR OROFACIAL DIAGNOSTICS AND THERAPEUTICS
#2709Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)
#2710Methods and compositions for delivering active agents with enhanced pharmacological properties
#2711Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
#2712Compositions and methods for treatment of retinal degenerative diseases
#2713COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA
#2714BETA-CASEIN A2 AND PREVENTION OF INFLAMMATION OF THE BOWEL
#2715TAFA4 compounds and uses thereof for treating pain
#2716Method for inhibiting HIV replication in mammal and human cells
#2717Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
#2718Apolipoprotein E polypeptides and their use
#2719THERAPEUTIC PEPTIDES
#2720Method for Inhibiting HIV Replication in Mammal and Human Cells
#2721Treatment of Mood and Anxiety Disorders
#2722NEUROTENSIN-INDUCED TUMOR FORMATION IS REGULATED BY MICRO RNA 133A-AFTIPHILIN-DEPENDENT RECEPTOR RECYCLING
#2723Novel Peptides Involved in Energy Homeostasis
#2724Compounds and methods of modulating angiogenesis
#2725Method for therapeutic replenishment and enrichment of ocular surface lubrication
#2726Viral vectors for the treatment of retinal dystrophy
#2727Compositions of active Wnt protein
#2728ApoE peptide dimers and uses thereof
#2729Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and HLA-E-bearing composition
#2730Lipoprotein complexes and manufacturing and uses thereof
#2731Transfer factor for improving fertility
#2732Compositions and methods for the removal of biofilms
#2733Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#2734Whey Protein and Resistant Starch Compositions to Reduce Body Mass Index
#2735Enzyme conjugate and prodrug cancer therapy
#2736NOVEL TREATMENT OF METABOLIC DISEASES
#2737Follistatin in treating duchenne muscular dystrophy
#2738Methods and compositions for treating trinucleotide repeat disorders
#2739Humanin, analogs and cancer treatment methods and uses thereof
#2740METHOD FOR SEPARATING AND PURIFING FUNCTIONAL INGREDIENTS FROM PLACENTA USING SUPERCRITICAL FLUID TECHNOLOGY
#2741CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS
#2742Compositions and methods for treating spinal muscular atrophy
#2743EFFECT OF PHOSPHOLIPID COMPOSITION OF RECONSTITUTED HDL ON ITS CHOLESTEROL EFFLUX AND ANTI-INFLAMMATORY PROPERTIES
#2744Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods
#2745Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics
#2746WNT MODULATORS FOR THE PROTECTION, MITIGATION AND TREATMENT OF RADIATION INJURY
#2747Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells
#2748Conjugate comprising P21 protein for the treatment of cancer
#2749Compositions and methods for the systemic treatment of arthritis
#2750Use of human small leucine zipper protein in osteogenesis procedure
#2751TREATMENT AGENT FOR COGNITIVE IMPAIRMENT INDUCED BY AMYLOID BETA-PROTEIN, THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE, AND TREATMENT METHOD AND PATHOLOGICAL ANALYSIS METHOD RELATED TO THESE
#2752Lamin A, an activator of longevity/anti-aging SIRT1 protein
#2753USE OF INSULIN SIGNALING ANTAGONISTS, OPTIONALLY IN COMBINATION OF TRANSFECTION OF NON-BETA CELLS, FOR INDUCING INSULIN PRODUCTION
#2754Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
#2755Islet1 (ISl1) and hearing loss
#2756Method for inducing hemoblast differentiation
#2757Modulation of Activity of Proneurotrophins
#2758Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#2759Composition including the HIP/PAP protein or one of the derivatives thereof for treating insulin resistance
#2760Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#2761COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES AND DISORDERS WITH APELIN
#2762Gene therapy for neurodegenerative disorders
#2763COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#2764COMBINED PROTEIN SUPPLEMENTS
#2765Biodegradable Bionanoparticles for Releasing the GSE24-2 Peptide, Method for the Production Thereof, and Use of Same
#2766FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY
#2767Modulators of alpha-synuclein toxicity
#2768MUSCLE-ATROPHY-PREVENTING AGENT
#2769Inhibition of choroidal neovascularization
#2770Stabilized mutant opsin proteins
#2771Compositions and methods for in vivo excision of HIV-1 proviral DNA
#2772B7-H4 fusion proteins and methods of use thereof
#2773Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#2774EIF4E binding peptides
#2775NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS
#2776Use of CD36 to identify cancer subjects for treatment
#2777Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods
#2778Compositions comprising hypoxia inducible factor-1 alpha and methods of using the same
#2779Fatty acids and their use in conjugation to biomolecules
#2780Immunity inducing agent
#2781PREVENTION, THERAPY AND PROGNOSIS/MONITORING IN SEPSIS AND SEPTIC SHOCK
#2782Use of antisecretory factors (AF) for optimizing cellular uptake
#2783Methods of using ZSCAN4 for rejuvenating human cells
#2784IL-18 inhibition for promotion of early hematopoietic progenitor expansion
#2785Modified T lymphocytes comprising an inducible caspase and methods of apoptosis
#2786COMPOSITIONS INCLUDING APOLIPOPROTEIN AND METHODS USING FOCUSED ACOUSTICS FOR PREPARATION THEREOF
#2787Treating hepatitis B virus infections by administering receptor associated protein (RAP)
#2788Oxidant resistant apolipoprotein A-1 and mimetic peptides
#2789Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
#2790Method of inhibiting angiogenesis using inhibitors of G-protein-coupled receptor kinase interacting protein-1 (GIT1)
#2791Potent and selective inhibitors of Nav1.7
#2792Sensation-improving agent
#2793USE OF GLYCOMACROPEPTIDE TO IMPROVE WOMEN'S HEALTH
#2794COMPOSTIONS AND METHODS FOR TREATING RETINAL DISEASE
#2795Reconstituted high density lipoprotein formulation and production method thereof
#2796Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
#2797Compositions and methods for treating conditions that affect epidermis
#2798Methods and compositions for delivering interleukin-1 receptor antagonist
#2799Combination of a light ray with a cytochrome C oxidase substrate particularly for improving the appearance of the skin and/or hair
#2800Use of angiogenin or angiogenin agonists for treating diseases and disorders
#2801Therapeutic modulation of ocular surface lubrication
#2802Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins
#2803Lipopeptides for use in treating liver diseases and cardiovascular diseases
#2804KETOGENIC FOOD COMPOSITIONS, METHODS, AND USES THEREOF
#2805Therapeutic and diagnostic methods relating to cancer stem cells
#2806Gla domains as targeting agents
#2807STIP1 polypeptides and uses thereof
#2808Therapeutic agent for amniotic fluid embolism
#2809ApoE peptide dimers and uses thereof
#2810Methods and compositions for treating genetically linked diseases of the eye
#2811MODIFIED INGAP PEPTIDES FOR TREATING DIABETES
#2812Treating human immunodeficiency virus infections
#2813Reversible pegylated drugs
#2814Exercise-regulated adipokines as therapy for diabetes management
#2815RECEPTOR-TARGETING REAGENTS
#2816Compositions and methods for modulating the immune system
#2817CTHRC1 RECEPTOR AND METHODS OF USE THEREOF
#2818Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration
#2819Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
#2820Treatments for lowering glucose levels using FGF binding protein 3
#2821Ligation of stapled polypeptides
#2822Milk-derived basic protein fraction as skin sensitivity improving agent
#2823Stanniocalcin-1 (STC-1) therapy for treatment of retinal diseases
#2824Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
#2825CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR
#2826GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE
#2827HUMAN DISEASE TREATMENT WITH MEDICAL FOOD FORMULATION
#2828Serpins: methods of therapeutic β-cell regeneration and function
#2829METHODS OF INCREASING NEURONAL CONNECTIVITY AND/OR TREATING A NEURODEGENERATIVE CONDITION
#2830Methods and Related Kits for Treating and Regenerating Tooth Pulp and Periapical Tissues in a Mammal
#2831METHOD AND COMPOSITION FOR CONFERRING NEUROPROTECTION
#2832THERAPEUTIC METHOD
#2833Transcription factor-based generation of pacemaker cells and methods of using same
#2834Methods to rebalance the hypothalamic-pituitary-gonadal axis
#2835Technology for the Preparation of Microparticles
#2836APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA
#2837Positive modulator of bone morphogenic protein-2
#2838ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#2839Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
#2840Method and compositions for genetic and retinal disease
#2841LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#2842Methods for treating myocardial infarction comprising administering sonic hedgehog
#2843Methods for treating tissue damage associated with ischemia with apolipoprotein D
#2844METHODS FOR REDUCING MUSCLE SORENESS AFTER EXERCISE USING BETA-HYDROXY-BETA-METHYLBUTYRATE
#2845Use of protectin DX for the stimulation of muscular IL-6 secretion
#2846Drug delivery means
#2847Compositions of active Wnt protein
#2848Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#2849OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS
#2850Treatment of diseases involving mucin
#2851BEVERAGE, AND METHOD OF PRODUCING THE SAME
#2852Hypotonic aqueous composition with reduced chloride content, with or without phospholipids
#2853METHODS FOR TREATING CANCER USING COMPOSITIONS COMPRISING HSS1 AND/OR HSM1
#2854TNNT1 mini-promoters
#2855RECOMBINANT LUBRICIN MOLECULES AND USES THEREOF
#2856Treatment of muscular dystrophy
#2857Administration of DKK1 muteins to treat fibrosis
#2858CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#2859OXIDIZED LDL INHIBITOR
#2860Colostrum Composition Enriched in Anti-Endotoxin Antibodies
#2861Methods and compositions for treating Huntington's Disease
#2862Inhibition of choroidal neovascularization
#2863MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE
#2864IL-17A binding molecules and medical uses thereof
#2865Inhibition of cancer growth and metastasis
#2866Protein SLURP-1 for use in the treatment of ocular diseases
#2867HDL THERAPY MARKERS
#2868Anti-inflammatory pharmaceutical products
#2869TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
#2870Materials and Methods for Regulating Whole Body Glucose Homeostasis
#2871Medicament for atrophy treatment or increasing cell growth
#2872METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TINNITUS
#2873Therapy for radiation-induced lung injury
#2874Reconstituted HDL formulation
#2875METHOD FOR DIAGNOSING AND TREATING KIDNEY INJURY OR DISEASE
#2876Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#2877Methods and compositions for modulating Toso activity
#2878Natriuretic polypeptides
#2879Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#2880CANCER-SPECIFIC SUICIDE GENE FOR CELL-BASED AND GENE THERAPY
#2881Inhibition of cardiac fibrosis in myocardial infarction
#2882XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
#2883COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES
#2884Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
#2885Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis
#2886Treatment of angiogenesis disorders
#2887Methods for treating colon cancer and inflammation associated with overexpression of human signal peptide-containing proteins
#2888Materials and methods useful for treating glioblastorna
#2889Combination treatment for amyotrophic lateral sclerosis (ALS)
#2890Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
#2891Method of promoting wound healing
#2892Therapeutic applications of SMAD7
#2893Pharmaceutical composition for use in the treatment of dysfunction associated with aging
#2894ENCAPSULATED BITTER PEPTIDES, METHODS OF ENCAPSULATING BITTER PEPTIDES, AND NUTRITIONAL COMPOSITIONS INCLUDING ENCAPSULATED BITTER PEPTIDES
#2895Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
#2896METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING IL-27 INDUCED PATHWAYS
#2897Natural tissue scaffolds as tissue fillers
#2898Chimeric fibronectin matrix mimetics and uses thereof
#2899Tear lipocalin muteins binding IL-4 R alpha
#2900Prevention and Treatment of Transplant Rejection with Mesenchymal Stem Cells and/or TSG-6 Protein
#2901CHAPERONIN 10 VARIANTS
#2902Method for treating cardiac infarction using HMGB1 fragment
#2903GENE THERAPY FOR GLYCOGEN STORAGE DISEASES
#2904Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis
#2905Peptide directed protein knockdown
#2906Methods of treating cognitive impairment
#2907Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)
#2908Treatment of Brain Injury or Trauma with TSG-6 Protein
#2909Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide
#2910Method for diagnosing a neurodegenerative disease
#2911Apolipoprotein AIV as an antidiabetic peptide
#2912Regenerating functional neurons for treatment of disease and injury in the nervous system
#2913Methods for treating neurological conditions and compositions and materials therefor
#2914VOLTAGE GATED CALCIUM CHANNEL BETA-SUBUNIT ANCHORING REGULATOR PROTEIN AND USES THEREOF
#2915METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE
#2916Methods and compositions for specific modulation of MCL-1
#2917Expanding the eukaryotic genetic code
#2918Use of PEDF-derived polypeptides for treating osteoarthritis
#2919DNA vaccines encoding heat shock proteins
#2920Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
#2921Methods for treating cardiac conditions
#2922INFANT FORMULA FOR OPTIMAL GROWTH, GASTROINTESTINAL PROTECTION AND IMMUNOLOGICAL PROTECTION OF INFANTS
#2923Methods for detecting the presence of irritable bowel syndrome and system for diagnosing same
#2924Fibronectin based scaffold domain proteins that bind to myostatin
#2925STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION
#2926COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE
#2927PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME
#2928Treatment of pain by inhibition of USP5 de-ubiquitinase
#2929Adeno-associated virus virions with variant capsid and methods of use thereof
#2930Method for regulating cell proliferation
#2931NANOCONSTRUCTS WITH PHARMACOLOGICAL ACTIVITY
#2932Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor
#2933Multifunctional nanobodies for treating cancer
#2934FCRN antagonists and methods of use
#2935Syndecan peptides and polypeptides as inhibitors of cancer
#2936Antimicrobial compositions comprising a hyaluronic acid binding peptide and a β-lactam antibiotic
#2937COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES USING SMAD3
#2938Recombinant VWF formulations
#2939Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3
#2940Extracellular vesicles comprising recombinant lysosomal transmembrane protein
#2941Semaphorin 3A for treatment and assessment of severity of Asthma
#2942METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES
#2943METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS
#2944HMGB1 variants and uses thereof
#2945Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof
#2946AAV-mediated gene therapy for RPGR X-linked retinal degeneration
#2947Method for preparing a bone protein preparation and a bone protein preparation
#2948Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
#2949TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#2950Medicament for wound treatment
#2951Methylation-controlled J protein (MCJ) for treatment of liver disease and altering mitochondrial metabolism
#2952Differentiation marker and differentiation control of eye cell
#2953Soluble MANF in pancreatic β-cell disorders
#2954Methods and compositions for modulating Toso activity
#2955COMPOSITIONS AND METHODS FOR DUCHENNE MUSCULAR DYSTROPHY GENE THERAPY
#2956Hypo-allergenic cross-linked proteins for use in the prevention of an allergy against milk-proteins and for use in the induction of oral tolerance
#2957Methods for diagnosing, prognosing and treating muscular dystrophy
#2958Angiopoietin-like 4 and a method of its use in wound healing
#2959Compositions suitable for treatment of spinal disease, disorder or condition
#2960OXYGEN-CONTROLLABLE AND HYPOXIA-INDUCIBLE HYDROGELS
#2961Method for producing a protein comprising composition with reduced digestive coagulation
#2962Methods and compositions for in vivo induction of pancreatic beta cell formation
#2963Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
#2964Human hepatocyte-like cells and uses thereof
#2965ANNELID HAEMOGLOBIN LYOPHILISATION PROCESS
#2966METHOD FOR MODULATING APPETITE
#2967HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS
#2968Antagonists of activin-ActRIIa and uses for increasing red blood cell levels
#2969Method of treating hyperglycemic disorders using apolipoprotein AIV
#2970TREATMENT OF MUSCULAR DYSTROPHIES AND RELATED DISORDERS
#2971SH2 domain variants
#2972Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#2973Generating hepatocytes
#2974Composition for preventing or treating fracture or osteoporosis using slit-robo system
#2975High-density lipoprotein coated medical devices and methods of treatment using the devices
#2976THERAPEUTIC METHOD FOR TREATING CONGESTIVE HEART FAILURE
#2977Anti-tumor properties of Dickkopf 3b
#2978Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
#2979PHARMACEUTICAL COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES
#2980Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
#2981CASEIN PRODUCTS AND C02 REVERSIBLE ACIDIFICATION METHODS USED FOR THEIR PRODUCTION
#2982COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE
#2983Lipid formulations
#2984Use of serine protease inhibitors in the treatment of neutropenia
#2985Systems and methods for angiogenic treatment in wound healing
#2986Method of treating type I diabetes using apolipoprotein A-IV
#2987METHOD FOR PRODUCING A PROTEIN AND LIPID COMPRISING COMPOSITION WITH REDUCED DIGESTIVE COAGULATION
#2988Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
#2989DEP2 AND ITS USES IN MAJOR DEPRESSIVE DISORDER AND OTHER RELATED DISORDERS
#2990CYSTEINE PROTEASE CAPTURING AGENTS
#2991Recombinant human CC10 protein for treatment of influenza and ebola
#2992THERAPIES FOR CANCER USING RLIP76
#2993Lipoprotein complexes and manufacturing and uses thereof
#2994Selective PYY compounds and uses thereof
#2995Peptides having activity of inhibiting infections of respiratory viruses and use of the same
#2996CHRONIC LYMPHOCYTIC LEUKEMIA PROGNOSIS AND TREATMENT
#2997TREFOIL FAMILY FACTOR PROTEINS AND USES THEREOF
#2998Apolipoprotein mixtures
#2999Mutant herpes simplex virus-2 for cancer therapy
#3000Controlled release of biological entities